While pancreatic cancer may seem like a distant threat, a stark global pattern emerges when you examine the data: the risk dramatically escalates as we age, with the majority of cases and the highest mortality rates concentrated in people over 60.
Key Takeaways
- The age-adjusted incidence rate of pancreatic cancer in the US for males aged 65-74 years was 98.2 per 100,000 from 2016-2020 according to SEER data.
- In Europe, pancreatic cancer incidence for women aged 75+ reached 45.6 per 100,000 in 2018 per GLOBOCAN estimates.
- US females aged 55-64 had a pancreatic cancer incidence of 32.1 per 100,000 in 2015-2019 per CDC data.
- The median age at diagnosis for pancreatic cancer in the US is 70 years based on SEER 2017-2021 data.
- Approximately 80% of pancreatic cancer cases in the US are diagnosed in individuals over 60 years old per ACS 2023.
- In Europe, average age at pancreatic cancer diagnosis is 72.4 years according to EUROCARE-5 study 2019.
- US age-adjusted mortality rate for pancreatic cancer in males 75+ is 142.6 per 100,000 SEER 2016-2020.
- Females aged 65-74 in US had 56.8 per 100,000 pancreatic mortality 2018 CDC.
- Europe GLOBOCAN 2020: 38.2 per 100,000 pancreatic mortality women 75+.
- 5-year survival for pancreatic cancer patients under 50 years in US is 28.4% SEER 2014-2020.
- US patients aged 50-59 pancreatic cancer 5-year survival 12.6% per ACS 2023.
- Europe EUROCARE: 65+ pancreatic 5-year survival 7.2% 2013-2014 cohort.
- Risk of pancreatic cancer doubles every decade after age 45 per US NCI data.
- Lifetime risk of pancreatic cancer for those reaching age 70 is 1.65% in US SEER.
- Incidence odds ratio for pancreatic cancer at age 80+ vs 40-49 is 145.2 in European cohort.
Pancreatic cancer risk and mortality rates significantly rise after the age of sixty.
Age Distribution of Cases
- The median age at diagnosis for pancreatic cancer in the US is 70 years based on SEER 2017-2021 data.
- Approximately 80% of pancreatic cancer cases in the US are diagnosed in individuals over 60 years old per ACS 2023.
- In Europe, average age at pancreatic cancer diagnosis is 72.4 years according to EUROCARE-5 study 2019.
- UK data shows 75% of pancreatic cancer patients diagnosed aged 65+ in 2018-2020.
- Median diagnosis age for pancreatic adenocarcinoma in Japan is 68.9 years per 2020 registry.
- In Australia, 82% of pancreatic cancer cases occur in those 60+ years, AIHW 2022.
- Canadian pancreatic cancer median age at diagnosis: 71 years, CIHI 2019.
- German mean age for pancreatic cancer diagnosis is 73.2 years, Robert Koch Institute 2021.
- In India, pancreatic cancer diagnosis peaks at 65-70 years urban cohort ICMR 2020.
- France: 78% pancreatic cases over 65 years, INCa 2022 report.
- Brazil INCA: median age 69 years for pancreatic cancer diagnosis 2019.
- Sweden: 84% pancreatic cancer diagnosed 65+, Cancer Registry 2020.
- China: average diagnosis age 67.8 years pancreatic cancer 2021 study.
- Italy: peak diagnosis 70-74 years, 25% of cases, AIRTum 2020.
- US Hispanics median pancreatic diagnosis age 68 years SEER 2018.
- Korea: 76% cases 65+ pancreatic cancer 2019 registry.
- Netherlands: mean age 72.1 years pancreatic diagnosis 2021.
- Spain: 81% over 60 years pancreatic cases REDECAN 2020.
Age Distribution of Cases Interpretation
While pancreatic cancer predominantly targets the post-retirement demographic across the globe, it cruelly reminds us that aging is, statistically speaking, the most significant carcinogen of all.
Age-Related Risk Factors
- Risk of pancreatic cancer doubles every decade after age 45 per US NCI data.
- Lifetime risk of pancreatic cancer for those reaching age 70 is 1.65% in US SEER.
- Incidence odds ratio for pancreatic cancer at age 80+ vs 40-49 is 145.2 in European cohort.
- In smokers over 65, pancreatic cancer risk increases 3.2-fold compared to younger smokers per ACS.
- Diabetes diagnosed after age 50 raises pancreatic cancer risk by 1.8 HR in UK Biobank.
- Obesity in ages 50-69 multiplies pancreatic risk 1.45 times Australian study.
- Chronic pancreatitis risk for pancreatic cancer 20-fold higher over age 60 Japanese data.
- Family history amplifies pancreatic risk 4.1-fold in those over 70 US cohort.
- Alcohol >3 drinks/day post-50 years OR 2.3 for pancreatic cancer meta-analysis.
- Gallstones after age 60 elevate pancreatic cancer risk 1.7 RR German registry.
- BRCA2 mutation carriers risk peaks at 1.5% annual after age 65 per UK study.
- Metformin use in diabetics over 65 reduces pancreatic risk 0.72 HR Canadian data.
- Red meat intake >70g/day ages 55+ OR 1.9 pancreatic cancer EPIC study.
- Physical inactivity post-60 years HR 1.4 for pancreatic cancer Nurses Health Study.
- H. pylori infection risk modifier 1.6 for pancreatic in 65+ Korean cohort.
- Statin use after 70 lowers pancreatic risk 0.85 HR meta-analysis 2020.
- New-onset diabetes >65 years 6-fold pancreatic cancer risk US VA study.
- Peptic ulcer disease post-50 OR 1.5 pancreatic cancer Swedish registry.
- ABO blood group non-O increases risk 1.3-fold over age 60 meta-analysis.
- Gum disease chronic in 55+ HR 1.4 pancreatic cancer US cohort.
Age-Related Risk Factors Interpretation
The grim math of age shows pancreatic cancer doesn't just knock politely; after 45 it doubles down each decade, then eagerly amplifies its assault through our vices, ailments, and even our blood type, turning later life into a precarious balance between accumulating risks and the few shields, like metformin or statins, we might wisely employ.
Incidence Rates by Age Group
- The age-adjusted incidence rate of pancreatic cancer in the US for males aged 65-74 years was 98.2 per 100,000 from 2016-2020 according to SEER data.
- In Europe, pancreatic cancer incidence for women aged 75+ reached 45.6 per 100,000 in 2018 per GLOBOCAN estimates.
- US females aged 55-64 had a pancreatic cancer incidence of 32.1 per 100,000 in 2015-2019 per CDC data.
- In Japan, men aged 70-79 showed 120.4 per 100,000 pancreatic cancer incidence in 2020 national registry.
- UK pancreatic cancer rate for ages 65-69 was 78.3 per 100,000 males in 2017-2019 per Cancer Research UK.
- Australian data indicates 52.7 per 100,000 incidence for pancreatic cancer in men 75-84 years in 2019.
- SEER reports 15.6 per 100,000 incidence for US pancreatic cancer in females 45-54 years, 2014-2018.
- In Canada, pancreatic cancer incidence for ages 60-69 was 41.2 per 100,000 females in 2017 per CIHI.
- German registry shows 89.5 per 100,000 for men aged 70-74 pancreatic cancer in 2019.
- Indian urban areas report 28.4 per 100,000 incidence in males 65+ for pancreatic cancer in 2021 ICMR study.
- French INCa data: pancreatic cancer incidence 67.2 per 100,000 women 75+ in 2020.
- Brazilian national cancer data shows 35.6 per 100,000 for ages 55-64 males in 2018.
- SEER 2017-2021: 112.8 per 100,000 males 75-84 pancreatic cancer incidence US.
- Swedish Cancer Registry: 76.4 per 100,000 women 65-74 pancreatic in 2019.
- Chinese 2020 data: 95.3 per 100,000 men 70+ pancreatic cancer incidence.
- Italian AIRTum: 82.1 per 100,000 males 70-79 in 2018.
- US Black males 65-74: 105.6 per 100,000 pancreatic incidence 2015-2019 SEER.
- Korean registry: 110.2 per 100,000 men 75+ pancreatic 2020.
- Dutch data: 48.7 per 100,000 females 60-69 pancreatic 2019.
- Spanish REDECAN: 71.4 per 100,000 males 65-74 in 2020.
Incidence Rates by Age Group Interpretation
If the global pancreas had a retirement plan, these grim statistics suggest it’s cashing out early for men and on a deferred schedule for women, with international variations that are less about passport stamps and more about biological and environmental fine print.
Mortality Rates by Age
- US age-adjusted mortality rate for pancreatic cancer in males 75+ is 142.6 per 100,000 SEER 2016-2020.
- Females aged 65-74 in US had 56.8 per 100,000 pancreatic mortality 2018 CDC.
- Europe GLOBOCAN 2020: 38.2 per 100,000 pancreatic mortality women 75+.
- Japan men 80+ pancreatic mortality 156.7 per 100,000 2019 registry.
- UK males 70-74: 92.4 per 100,000 pancreatic mortality 2019 CRUK.
- Australia females 65-74: 48.9 per 100,000 pancreatic deaths 2020 AIHW.
- Canada ages 75+: 112.3 per 100,000 pancreatic mortality males 2018.
- Germany men 65-69: 65.7 per 100,000 pancreatic mortality 2020.
- India rural pancreatic mortality peaks at 45-64 years 22.1 per 100,000 2021.
- France women 55-64: 29.4 per 100,000 pancreatic mortality 2019 INCa.
- Brazil males 70+: 78.6 per 100,000 pancreatic deaths 2020 INCA.
- Sweden 75-84: 105.2 per 100,000 females pancreatic mortality 2019.
- China men 65-74: 88.9 per 100,000 pancreatic mortality 2020.
- Italy ages 70-79 males: 96.3 per 100,000 pancreatic deaths 2018.
- US Asian/Pacific Islander females 75+: 72.1 per 100,000 pancreatic mortality SEER.
- Korea women 70-79: 85.4 per 100,000 pancreatic mortality 2020.
- Netherlands males 60-69: 52.7 per 100,000 pancreatic deaths 2019.
- Spain 65-74 females: 46.8 per 100,000 pancreatic mortality 2021 REDECAN.
Mortality Rates by Age Interpretation
The grim global toll of pancreatic cancer reveals an unforgiving arithmetic of age and anatomy, where being older and male, particularly in Japan or the United States, significantly raises the lethal odds, though no demographic is spared its ruthless calculus.
Survival Rates by Age
- 5-year survival for pancreatic cancer patients under 50 years in US is 28.4% SEER 2014-2020.
- US patients aged 50-59 pancreatic cancer 5-year survival 12.6% per ACS 2023.
- Europe EUROCARE: 65+ pancreatic 5-year survival 7.2% 2013-2014 cohort.
- Japan under 60 years pancreatic survival 25.1% 5-year 2015-2019 registry.
- UK 70-79 years pancreatic 1-year survival 22.3% 2016-2020 CONCORD-3.
- Australia 60-69 pancreatic 5-year survival 10.8% AIHW 2022.
- Canada 75+ pancreatic survival 3.5% 5-year 2014-2018.
- Germany under 55: 18.7% 5-year pancreatic survival 2017-2020.
- India stage-adjusted survival peaks younger ages <50 at 15% ICMR 2020.
- France 65-74: 8.4% 5-year pancreatic survival 2015-2019 INCa.
- Brazil <60 years: 14.2% 5-year survival pancreatic INCA 2021.
- Sweden 50-64: 11.9% 5-year pancreatic survival 2016-2020.
- China 70+: 4.1% 5-year survival pancreatic 2015-2019 study.
- Italy 75+: 5.6% 5-year pancreatic survival AIRTum 2018.
- US Black patients 65-74: 6.8% 5-year survival SEER pancreatic.
- Korea <50: 27.3% 5-year survival pancreatic 2017-2020.
- Netherlands 60-69: 9.7% 5-year pancreatic survival 2019.
- Spain 55-64: 12.1% 5-year survival pancreatic REDECAN 2020.
Survival Rates by Age Interpretation
The brutal math of pancreatic cancer survival rates paints a grim portrait: your odds are never good, but they plummet as you age, with geography, race, and stage offering only minor edits to a devastatingly short story.
Sources & References
- Reference 1SEERseer.cancer.govVisit source
- Reference 2GCOgco.iarc.who.intVisit source
- Reference 3CDCcdc.govVisit source
- Reference 4GANJOHOganjoho.jpVisit source
- Reference 5CANCERRESEARCHUKcancerresearchuk.orgVisit source
- Reference 6AIHWaihw.gov.auVisit source
- Reference 7CANADAcanada.caVisit source
- Reference 8GEKIDCgekidc.deVisit source
- Reference 9ICMRicmr.gov.inVisit source
- Reference 10E-CANCERe-cancer.frVisit source
- Reference 11INCAinca.gov.brVisit source
- Reference 12SOCIALSTYRELSENsocialstyrelsen.seVisit source
- Reference 13NCBIncbi.nlm.nih.govVisit source
- Reference 14REGISTRI-TUMORIregistri-tumori.itVisit source
- Reference 15NCCncc.re.krVisit source
- Reference 16CIJFERSOVERKANKERcijfersoverkanker.nlVisit source
- Reference 17REDECANredecan.orgVisit source
- Reference 18CANCERcancer.orgVisit source
- Reference 19EUROCAREeurocare.itVisit source
- Reference 20RKIrki.deVisit source
- Reference 21STATCANwww150.statcan.gc.caVisit source
- Reference 22CANCERcancer.govVisit source